Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 0.8864 USD 4.43% Market Closed
Market Cap: 100.5m USD

Accuray Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Accuray Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Accuray Inc
NASDAQ:ARAY
Operating Income
$1.5m
CAGR 3-Years
-25%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$3.5B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$3.8B
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Operating Income
$5.4B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Operating Income
$8B
CAGR 3-Years
-6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
15%
No Stocks Found

Accuray Inc
Glance View

Market Cap
100.4m USD
Industry
Health Care

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

ARAY Intrinsic Value
4.706 USD
Undervaluation 81%
Intrinsic Value
Price

See Also

What is Accuray Inc's Operating Income?
Operating Income
1.5m USD

Based on the financial report for Sep 30, 2025, Accuray Inc's Operating Income amounts to 1.5m USD.

What is Accuray Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-42%

The average annual Operating Income growth rates for Accuray Inc have been -25% over the past three years , -42% over the past five years .

Back to Top